Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHRW | -20.52% | $12.25B | +18.83% | 2.39% |
CWAN | -18.27% | $6.23B | +37.40% | 0.00% |
APD | -17.97% | $63.44B | +6.85% | 2.42% |
TMUS | -14.36% | $250.11B | +31.99% | 1.34% |
OMCL | -13.13% | $2.00B | +22.17% | 0.00% |
EXAS | -12.78% | $10.49B | -19.16% | 0.00% |
K | -12.46% | $28.11B | +46.16% | 2.77% |
VSTA | -12.41% | $184.39M | -44.44% | 0.00% |
AFL | -11.80% | $57.54B | +25.33% | 1.98% |
LH | -11.02% | $19.60B | +3.97% | 1.24% |
CATO | -10.70% | $73.73M | -49.37% | 14.37% |
IDCC | -10.36% | $4.84B | +82.83% | 1.12% |
MNOV | -10.00% | $97.60M | +33.11% | 0.00% |
FTDR | -9.82% | $4.30B | +72.23% | 0.00% |
XBIO | -9.56% | $6.29M | +11.39% | 0.00% |
CHE | -9.22% | $7.97B | -8.87% | 0.34% |
MSDL | -9.07% | $1.82B | +0.47% | 9.86% |
ALL | -8.83% | $50.79B | +27.60% | 2.02% |
SNN | -8.60% | $10.60B | -11.14% | 3.12% |
CALM | -8.02% | $5.11B | +92.02% | 2.82% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MTLS | <0.01% | $439.16M | +20.11% | 0.00% |
RNR | -0.03% | $13.16B | +26.25% | 0.63% |
BTU | 0.03% | $2.31B | -20.36% | 1.64% |
FDX | -0.04% | $66.21B | +9.60% | 1.98% |
NTZ | 0.05% | $53.64M | -24.50% | 0.00% |
ROL | -0.07% | $22.45B | +7.07% | 1.32% |
IRM | 0.07% | $30.18B | +53.10% | 2.72% |
OPTN | 0.10% | $56.91M | -69.81% | 0.00% |
MYE | 0.11% | $400.54M | -42.42% | 5.12% |
DRVN | 0.12% | $2.54B | +14.73% | 0.00% |
KSPI | -0.14% | $18.18B | -1.44% | 3.96% |
CIG.C | 0.15% | $2.25B | +0.25% | 0.00% |
SRAD | 0.15% | $5.53B | +62.24% | 0.00% |
DOCU | 0.15% | $18.08B | +59.53% | 0.00% |
WCN | -0.15% | $45.41B | +18.39% | 0.67% |
XNET | 0.17% | $133.12M | +38.16% | 0.00% |
MFG | -0.18% | $64.41B | +46.40% | 3.24% |
ALAR | -0.22% | $74.95M | +1.88% | 0.00% |
IMNN | -0.22% | $13.19M | +36.77% | 0.00% |
OHI | 0.23% | $10.21B | +24.11% | 7.33% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CGNX | 41.08% | $6.43B | -4.39% | 0.82% |
LAB | 36.71% | $651.45M | -8.85% | 0.00% |
MYRG | 35.93% | $2.35B | +6.30% | 0.00% |
COHU | 35.53% | $1.23B | -20.98% | 0.00% |
IR | 34.48% | $35.96B | +16.96% | 0.09% |
VNT | 34.22% | $5.43B | +7.63% | 0.28% |
CACC | 33.63% | $5.51B | -15.52% | 0.00% |
ARVN | 33.04% | $1.36B | -48.88% | 0.00% |
VRNT | 32.92% | $1.56B | -7.30% | 0.00% |
AME | 32.92% | $41.28B | +9.02% | 0.63% |
FBRT | 32.41% | $1.01B | -11.29% | 11.76% |
MRNA | 31.80% | $16.61B | -60.56% | 0.00% |
PKST | 31.67% | $383.47M | -36.96% | 8.70% |
CMCO | 31.63% | $1.01B | -4.37% | 0.82% |
ALLO | 31.54% | $492.73M | -25.87% | 0.00% |
PTVE | 31.50% | $3.15B | +23.09% | 2.28% |
BPMC | 31.40% | $5.76B | +8.94% | 0.00% |
ECVT | 31.20% | $864.50M | -18.01% | 0.00% |
WDC | 30.99% | $22.15B | +26.83% | 0.00% |
KN | 30.82% | $1.76B | +17.29% | 0.00% |
Current Value
$1.811 Year Return
Current Value
$1.811 Year Return
Yahoo
As the U.S. stock market experiences fluctuations, with major indices showing slight gains and losses, investors are keeping a close eye on economic indicators that could influence interest rate decisions. Amidst these market dynamics, penny stocks continue to capture attention for their potential growth opportunities at lower price points. Although often associated with smaller or newer companies, these stocks can offer significant upside when backed by strong financials and solid fundamentals.
Yahoo
Here is how ALX Oncology Holdings Inc. (ALXO) and Ginkgo Bioworks Holdings, Inc. (DNA) have performed compared to their sector so far this year.
Yahoo
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives, today announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer, Jason Lettmann, will deliver a company overview presentation on Wednesday, January 15, 2025, at 3:00 p.m. Pacific
Yahoo
Jefferies downgraded the shares of ALX Oncology (ALXO) to hold from buy while cutting its price targ
Yahoo
Shares of Alx Oncology (NASDAQ:ALXO) fell in pre-market trading Thursday after Jefferies downgraded the stock to "hold" rating from a "buy," citing concerns over the company's clinical trial results and the higher burden of proof for its flagship drug, evorpacept. Jefferies analysts noted that while ALX Oncology initially generated investor excitement with its Phase II interim results in gastric cancer, the complete dataset revealed weaker outcomes. Jefferies highlighted challenges in the ongoing trials for head and neck cancer, with early data showing only modest differentiation from existing treatments like Keytruda.
Yahoo
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives, today announced that the updated results from its Phase 2 ASPEN-06 clinical trial have been accepted for oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, which will b
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILS | -0.06% | $3.33B | 0.1356% |
GSG | -0.13% | $1.02B | 0.75% |
COMT | -0.14% | $694.40M | 0.48% |
USTB | 0.14% | $912.18M | 0.35% |
SCHO | 0.15% | $11.29B | 0.03% |
BSV | 0.17% | $33.56B | 0.04% |
FLTR | 0.21% | $1.95B | 0.14% |
STXT | -0.26% | $123.46M | 0.49% |
SHYD | -0.36% | $312.26M | 0.35% |
TIPX | 0.50% | $1.37B | 0.15% |
GSY | 0.53% | $2.43B | 0.23% |
HTAB | 0.53% | $443.88M | 0.39% |
XMPT | 0.55% | $222.58M | 1.98% |
VTIP | 0.56% | $12.01B | 0.04% |
FTSM | -0.72% | $6.16B | 0.45% |
STIP | -0.73% | $10.73B | 0.03% |
ICLO | -0.78% | $287.21M | 0.2% |
FTGC | 0.85% | $2.24B | 1.02% |
SEIX | 0.88% | $300.05M | 0.62% |
GBIL | 0.90% | $5.84B | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -18.80% | $195.31M | 0.85% |
TAIL | -13.51% | $65.56M | 0.59% |
USDU | -12.07% | $379.83M | 0.5% |
CLOI | -11.56% | $792.56M | 0.4% |
JUCY | -10.27% | $301.67M | 0.6% |
UUP | -9.38% | $603.95M | 0.77% |
FBY | -8.70% | $165.62M | 0.99% |
XBIL | -7.69% | $641.82M | 0.15% |
WEAT | -7.49% | $119.67M | 0.28% |
UNG | -7.39% | $746.57M | 1.06% |
CANE | -7.01% | $12.08M | 0.29% |
TOTL | -5.43% | $3.37B | 0.55% |
DBE | -5.33% | $48.32M | 0.77% |
IVOL | -5.21% | $451.42M | 1.02% |
KRBN | -4.97% | $199.62M | 0.85% |
FLDR | -4.95% | $668.27M | 0.15% |
BIL | -4.31% | $36.56B | 0.1356% |
VNLA | -4.30% | $2.32B | 0.23% |
CORN | -3.43% | $63.58M | 0.2% |
FLRN | -3.42% | $2.46B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 38.84% | $270.13M | 0% |
EFAA | 35.50% | $104.22M | 0% |
IWC | 35.47% | $965.33M | 0.6% |
QQA | 34.20% | $144.94M | 0% |
IWM | 31.19% | $72.22B | 0.19% |
GSSC | 31.09% | $529.38M | 0.2% |
VTWO | 31.08% | $12.40B | 0.1% |
IWO | 30.84% | $12.83B | 0.24% |
PRFZ | 30.69% | $2.56B | 0.39% |
PSC | 30.44% | $733.12M | 0.38% |
XPH | 30.37% | $158.74M | 0.35% |
IBB | 30.14% | $6.59B | 0.45% |
IWN | 30.05% | $12.27B | 0.24% |
KOMP | 29.97% | $2.13B | 0.2% |
VEGI | 29.94% | $88.61M | 0.39% |
SNSR | 29.93% | $233.49M | 0.68% |
BSVO | 29.71% | $1.49B | 0.47% |
EES | 29.62% | $641.19M | 0.38% |
NUSC | 29.55% | $1.24B | 0.31% |
SPHB | 29.41% | $373.63M | 0.25% |